Management of venous thromboembolism: Why not treat it at home?;La prise en charge de la thromboembolie veineuse: Pourquoi ne pas la traiter à domicile?

Canadian Family Physician

Volumn 51, Issue FEB., 2005, Pages 181-188

  Spyropoulos, Alex C ^a,b  

^a Lovelace Sandia Health Systems   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; FONDAPARINUX; HEPARIN; IDRAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; XIMELAGATRAN;

ANTICOAGULATION; BLEEDING; CLINICAL PROTOCOL; CLINICAL TRIAL; EDITORIAL; HEALTH SERVICE; HOME CARE; HUMAN; LONG TERM CARE; PATIENT MONITORING; PATIENT SELECTION; PREGNANCY; QUALITY OF LIFE; RISK ASSESSMENT; THROMBOCYTOPENIA; VENOUS THROMBOEMBOLISM;

HEPARIN, LOW-MOLECULAR-WEIGHT; HOME INFUSION THERAPY; HUMANS; PATIENT SELECTION; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 14044278148     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (7)

1. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:677-81.
2. Koopman MW, Prandoni P, Piovella F, Ockelford PA, Brandjes DP, van der Meer J, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl Med 1996;334:682-7.
3. Harrison L, McGinnis J, Crowther M, Ginsberg J, Hirsh J. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin. Arch Intern Med 1998;158:2001-3.
4. Tillman DJ, Charland SL, Witt DM. Effectiveness and economic impact associated with a program for outpatient management of acute deep vein thrombosis in a group model health maintenance organization. Arch Intern Med 2000;160:2926-32.
5. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):401S-28S.
6. Spyropoulos AC. Outpatient-based treatment protocols in the management of venous thromboembolic disease. Am J Manag Care 2000;6(20 Suppl):S1034-44.
7. Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism [published erratum appears in N Engl J Med 2004;350:423]. N Engl J Med 2003;349:1695-702.